Alembic Pharmaceuticals Limited (APLLTD) Share Analysis
NSE · Healthcare · Healthcare
Alembic Pharmaceuticals Limited (NSE: APLLTD) is an Indian listed company in the Healthcare sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹846.00, market capitalisation ₹16,624 Cr, P/E 22.3, ROE 13.4%.
Get the AI verdict on APLLTD: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
APLLTD price and valuation
- Share price
- ₹846.00
- Market cap
- ₹16,624 Cr
- P/E ratio
- 22.3
- P/B ratio
- 2.93
- EPS
- ₹35.27
- Book value per share
- ₹289.00
- Dividend yield
- 1.42%
APLLTD profitability and growth
- ROE
- 13.4%
- ROCE
- 12.6%
- Debt to equity
- 0.25
- Revenue growth (3 yr)
- 9%
- Revenue growth (5 yr)
- 6%
- Profit growth (3 yr)
- 28%
- Profit growth (5 yr)
- -9%
APLLTD 52-week range
- 52-week high
- ₹998.00
- 52-week low
- ₹635.80
- Face value
- ₹2.00
APLLTD shareholding pattern
- Promoters
- 69.87%
- FIIs
- 4.17%
- DIIs
- 15.93%
- Public
- 10%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.